Suchergebnisse - (Person:"Wang, Ling")

PubPharm (99)

1

STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K/AKT signaling

enthalten in: Expert opinion on drug safety | 2024

von Wang, L. | Cao, J. | Tao, J. | +1

2

Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec498 Residue of Cytosolic Selenoprotein Thioredoxin Reductase

enthalten in: Molecules (Basel, Switzerland) | 2023

von Liu, M. | Sun, S. | Meng, Y. | +7

3

DeepCancerMap : A versatile deep learning platform for target- and cell-based anticancer drug discovery

enthalten in: European journal of medicinal chemistry | 2023

von Wu, J. | Xiao, Y. | Lin, M. | +6

4

Novel terpestacin derivatives with l-amino acid residue as anticancer agents against U87MG-derived glioblastoma stem cells

enthalten in: Bioorganic chemistry | 2023

von Liao, S. | Yuk, N. | Kim, Y. | +5

5

VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway

enthalten in: Journal of translational medicine | 2023

von Chen, Z. | Zhang, M. | Liu, Y. | +7

6

Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia

enthalten in: Bioorganic & medicinal chemistry | 2022

von Zhang, H. | Huang, J. | Chen, R. | +6

7

Anticancer effects of disulfiram : a systematic review of in vitro, animal, and human studies

enthalten in: Systematic reviews | 2022

von Wang, L. | Yu, Y. | Zhou, C. | +2

8

Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer

enthalten in: Journal of biomedical science | 2022

von Liu, J. | Fang, W. | Yang, S. | +12

9

Synthesis and bioevaluation of diaryl urea derivatives as potential antitumor agents for the treatment of human colorectal cancer

enthalten in: European journal of medicinal chemistry | 2022

von Wu, C. | Wang, Q. | Chen, R. | +13

10

The cyclin-dependent kinase inhibitor AT7519 augments cisplatin's efficacy in ovarian cancer via multiple oncogenic signaling pathways

enthalten in: Fundamental & clinical pharmacology | 2022

von Wang, L. | Chen, Y. | Li, H. | +2

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]